Psilocybin for anxiety disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Also followed for narrower conditions: Generalized Anxiety Disorder, Obsessive-Compulsive Disorder

Why this status

  1. 21 Jun 2021: Trial registered, NCT04932434
  2. 15 Aug 2021: Trial started, NCT04932434
  3. 10 Jan 2024: Trial registered, NCT06200155
  4. 16 Apr 2024: Trial started, NCT06200155
  5. 30 Jan 2025: Trial registered, NCT06801041
  6. 23 May 2025: Trial started, NCT06801041

The trials

NCT00465595: Psychopharmacology of Psilocybin in Cancer Patients

State
Completed
Phase
Phase 2
People
56 taking part
Started
Apr 2007
Primary completion
Dec 2014
Arms
Low Dose First, High Dose Second, High Dose First, Low Dose Second
Results
Posted on the registry
  1. 25 Apr 2007: Trial registered
  2. 19 Jul 2018: Trial results posted

NCT04932434: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease

State
Completed
Phase
Phase 2
People
12 taking part
Started
15 Aug 2021
Primary completion
31 Dec 2024
Arms
Psilocybin therapy
Results
Posted on the registry
  1. 21 Jun 2021: Trial registered
  2. 15 Aug 2021: Trial started
  3. 31 Dec 2024: Trial completed
  4. 3 Sep 2026: Trial results posted

NCT06200155: Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

State
Under way
Phase
Phase 2
People
48 planned
Started
16 Apr 2024
Primary completion
31 Dec 2026
Arms
Arm A
Results
None posted
  1. 10 Jan 2024: Trial registered
  2. 16 Apr 2024: Trial started

NCT06444243: Psilocybin-assisted Therapy for Alcohol Use Disorder

State
State not given
Phase
Phase 2
People
90 planned
Started
Sep 2024
Primary completion
Jul 2025
Arms
Psilocybin + Therapy
Results
None posted
  1. 5 Jun 2024: Trial registered

NCT06801041: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

State
Under way
Phase
Phase 2
People
20 planned
Started
23 May 2025
Primary completion
31 Mar 2027
Arms
Treatment with Psilocybin
Results
None posted
  1. 30 Jan 2025: Trial registered
  2. 23 May 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as High Dose Psilocybin, Low Dose Psilocybin, Medium Dose Psilocybin, Psilocybin (0.25mg/kg), Psilocybin (Usona Institute), Psilocybin (drug), Psilocybin 100 mcg/kg, Psilocybin 25 mg, Psilocybin 25 mg per os, Psilocybin 25mg, Psilocybin assisted therapy, Psilocybin first, Psilocybin plus Visual Healing Set and Setting, Psilocybin therapy, psilocybin 25 mg sod.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.